跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 393 条关于
“Pluri”
全部
393
临床试验
123
药物
64
机构
1
资讯
205
9个月前
Pluri Expands Manufacturing Partnership with Remedy Cell, Achieves Clinical-Grade Production for Fibrotic Disease Therapy
去年
Mesoblast Receives FDA Approval for First MSC Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease
7个月前
Pluri Secures China Patent for Large-Scale Immune Cell Manufacturing Platform
去年
Alpha Teknova and Pluristyx Partner to Advance Allogeneic Cell Therapy Manufacturing with Novel Cryopreservation System
去年
Pluristyx Secures Strategic Investment to Advance iPSC Technologies and Gene-Edited Cell Lines
去年
Kadimastem and NLS Pharmaceutics Merge to Advance ALS Therapy AstroRx
10个月前
Pluristyx Secures $1.4M from Breakthrough T1D to Develop Universal Immune-Cloaked Cell Line for Type 1 Diabetes Therapies
去年
Ipsell's Stem Cell Therapy 'Mucon' Shows Promise in Osteoarthritis Treatment
去年
Applied StemCell Launches Hypoimmunogenic hiPSC Products to Advance Allogeneic Cell Therapy Development
去年
uBriGene Launches GMP-Compliant iPSC Banks to Accelerate Cell Therapy Development
第 1 页,共 21 页
上一页
下一页